Patents by Inventor Kimberly M. Huber

Kimberly M. Huber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150359766
    Abstract: mGluR5 antagonists are used for the treatment of autism. The human treated by the methods of the invention can also have fragile X syndrome, epilepsy and anxiety.
    Type: Application
    Filed: January 26, 2015
    Publication date: December 17, 2015
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Publication number: 20100210542
    Abstract: mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.
    Type: Application
    Filed: January 15, 2010
    Publication date: August 19, 2010
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Patent number: 7648993
    Abstract: mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: January 19, 2010
    Assignees: Brown University, Emory University
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Patent number: 6916821
    Abstract: mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: July 12, 2005
    Assignees: Brown University, Emory University
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Patent number: 6890931
    Abstract: Compositions and uses of mGluR5 antagonists for the treatment and prevention of neurological disorders, such as Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome, are disclosed.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: May 10, 2005
    Assignees: Brown University, Emory University
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Publication number: 20040067978
    Abstract: mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.
    Type: Application
    Filed: April 4, 2003
    Publication date: April 8, 2004
    Applicants: Brown University Research Foundation (BURF), Emory University
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren
  • Publication number: 20030100539
    Abstract: Compositions and uses of mGluR5 antagonists for the treatment and prevention of neurological disorders, such as Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome, are disclosed.
    Type: Application
    Filed: April 2, 2002
    Publication date: May 29, 2003
    Inventors: Mark F. Bear, Kimberly M. Huber, Stephen T. Warren